SEC Filing Summary: Muscle Maker, Inc. (8-K)
Business Context and Reporting Period
Company: Muscle Maker, Inc. (Note: Request metadata referenced "Sadot Group Inc.", but the filing text identifies the issuer as Muscle Maker, Inc.)
Date of Report: December 11, 2019
Reporting Period: Event date December 5, 2019 (Board approval); Effective date December 11, 2019.
Context: The Company, a Nevada corporation and emerging growth company, filed this report to disclose a material modification to the rights of security holders via a reverse stock split. This action is being taken in connection with an application to list common stock on the NASDAQ Capital Market and a proposed public offering.
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a corporate action and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes Versus Prior Period
The primary material change is the implementation of a 1-for-7 reverse stock split of authorized, issued, and outstanding common stock. Fractional shares resulting from the split are rounded up to the nearest whole share. The changes in share counts are as follows:
- Authorized Shares: Reduced from 100,000,000 to 14,285,714.
- Issued and Outstanding Shares: Reduced from 40,226,258 to 5,746,608.
- Shares Reserved for Options/Warrants: Reduced from 17,185,725 to 2,455,108.
The par value of the common stock remains unchanged. Stockholder percentage ownership and proportional voting power remain unchanged, subject to minor adjustments due to fractional share rounding.
Guidance, Outlook, and Risks
Outlook: The reverse stock split is a prerequisite for the Company's application to list on the NASDAQ Capital Market and a related proposed public offering.
Regulatory Context: Under Nevada law (NRS Section 78.209), the Board of Directors approved the split without stockholder approval, as the reduction was proportional, did not adversely affect other stock classes, and no cash or scrip was issued for fractional shares.
Risks/Contingencies: The filing does not explicitly detail new risks, though the success of the NASDAQ listing and public offering remains contingent on regulatory approval and market conditions.
Investor Verification Checklist
- Verify the effective date of the 1-for-7 reverse stock split (December 11, 2019) and its impact on current shareholdings.
- Confirm the status of the Company's application to list on the NASDAQ Capital Market.
- Review the treatment of fractional shares (rounded up to the nearest whole share) to calculate exact post-split holdings.
- Check for subsequent filings regarding the proposed public offering mentioned in the text.
- Clarify the discrepancy between the request metadata ("Sadot Group Inc.") and the filing issuer ("Muscle Maker, Inc.").